title: Cyproheptadine: A Potentially Effective Treatment for Functional Gastrointestinal Disorders in Children.
abstract: Functional gastrointestinal disorders (FGIDs) negatively affect children's quality of life and health care costs. It has been proposed that alteration of gut serotonin leads to gastrointestinal dysmotility, visceral hypersensitivity, altered gastrointestinal secretions, and brain-gut dysfunction. Cyproheptadine, a serotonin antagonist, has been shown to be a potentially effective and safe treatment option in children who meet the clinical criteria for FGIDs. Well-designed multicenter trials with long-term follow-up are needed to further investigate its efficacy. [Pediatr Ann. 2017;46(3):e120-e125.].
authors.forename: Amornluck
authors.initials: A
authors.lastname: Krasaelap
authors.forename: Shailender
authors.initials: S
authors.lastname: Madani
mesh_terms: D002648:Child; D003533:Cyproheptadine / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D016896:Treatment Outcome
chemical_list: D005765:Gastrointestinal Agents; D003533:Cyproheptadine